In recent years, with the continuous reform of the medical Chinese, people are driving the market demand for in vitro diagnostic reagents is more and more concerned about their own health, and vigorously support the national policy, in vitro diagnostic reagents for the future will become the high incidence of mergers and acquisitions industry zone. IVD definition

The industry commonly known as IVD is the English Vitro Diagnostic In. In vitro diagnostic reagents and instruments are unified in foreign countries called in vitro diagnostic medical devices. Part of a medical device. In our country, in vitro diagnostic reagents is: can be used alone or with instruments, apparatus, equipment or system in the process of forecast combination, disease prevention, diagnosis, treatment, monitoring and prognosis observation, health evaluation and genetic diseases, for human samples (the humoral and cellular and tissue samples.) in vitro detection reagent kit, calibrator (object) and quality control (of) etc..

Connotation and market classification

In vitro diagnostic products include the collection of human samples (including body fluids, cells, tissue samples, etc.), preparation (directional processing), testing reagents instruments and analysis system.

Usually in vitro diagnostics market is mainly divided into four categories: biochemical reagents, immune diagnosis, molecular diagnosis, real-time test (POCT). According to the "blue book" data: 2014, segments of in vitro diagnostics for the overall market share of the top three: accounting for nearly 40% of the immune diagnosis (38%), accounting for nearly 20% of the biochemical reagent (19%) and accounted for 15% of the molecular diagnosis. At present, the largest share of the market is immune diagnosis.

The biochemical reagent products mainly to domestic brands; immune diagnostic products imported as the leading domestic brands occupy a certain share; molecular diagnostic products are imported and domestic brands in terms of POCT dragons and fishes jumbled together; products are mainly imported, domestic is still in the initial stage.

Current status of domestic and in vitro diagnostics industry

Chinese Pharmaceutical Industry Information Center released the "blue book" shows that in 2014 China's total medical device market reached 276 billion yuan, according to the market share, the top three are: market accounted for nearly 20% of the medical imaging equipment (19%), the market accounted for in vitro diagnostic products and market accounted for 16% of the high value medical supplies and implants for 13%. The IVD industry has become the medical market an important growth pole.

 

 

In recent years, with the continuous reform of the medical Chinese, people are driving the market demand for in vitro diagnostic reagents is more and more concerned about their own health, and vigorously support the national policy, in vitro diagnostic reagents for the future will become the high incidence of mergers and acquisitions industry zone. IVD definition

The industry commonly known as IVD is the English Vitro Diagnostic In. In vitro diagnostic reagents and instruments are unified in foreign countries called in vitro diagnostic medical devices. Part of a medical device. In our country, in vitro diagnostic reagents is: can be used alone or with instruments, apparatus, equipment or system in the process of forecast combination, disease prevention, diagnosis, treatment, monitoring and prognosis observation, health evaluation and genetic diseases, for human samples (the humoral and cellular and tissue samples.) in vitro detection reagent kit, calibrator (object) and quality control (of) etc..

Connotation and market classification

In vitro diagnostic products include the collection of human samples (including body fluids, cells, tissue samples, etc.), preparation (directional processing), testing reagents instruments and analysis system.

Usually in vitro diagnostics market is mainly divided into four categories: biochemical reagents, immune diagnosis, molecular diagnosis, real-time test (POCT). According to the "blue book" data: 2014, segments of in vitro diagnostics for the overall market share of the top three: accounting for nearly 40% of the immune diagnosis (38%), accounting for nearly 20% of the biochemical reagent (19%) and accounted for 15% of the molecular diagnosis. At present, the largest share of the market is immune diagnosis.

The biochemical reagent products mainly to domestic brands; immune diagnostic products imported as the leading domestic brands occupy a certain share; molecular diagnostic products are imported and domestic brands in terms of POCT dragons and fishes jumbled together; products are mainly imported, domestic is still in the initial stage.

Current status of domestic and in vitro diagnostics industry

Chinese Pharmaceutical Industry Information Center released the "blue book" shows that in 2014 China's total medical device market reached 276 billion yuan, according to the market share, the top three are: market accounted for nearly 20% of the medical imaging equipment (19%), the market accounted for in vitro diagnostic products and market accounted for 16% of the high value medical supplies and implants for 13%. The IVD industry has become the medical market an important growth pole.